Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Original source ↗  |  February 18, 2026 at 15:15 UTC  |  Finnhub - JNJ

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
JNJ
NONE Finnhub News